http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H035464-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 1990-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c628c1af713df14ccb6f2f06eed504d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e8ba5876fc5f80215fb630d84003db5
publicationDate 1991-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H035464-A
titleOfInvention Benzimidazole derivative, preparation thereof, pharmaceutical composition for treating hypertension and congestive heat failure, and intermediate
abstract NEW MATERIAL: A compound of formula I (wherein R 1 is a 1-8C alkyl, phenyl, etc.; R 2 -R 4 are each H, a 1-4C alkyl, a halogen, NO 2 , CF 3 , etc.; X is a single bond, phenylene, etc.; Z is 1H-tetrazol-5-yl or formula II-III; R 5 is H or a nontoxic biodegradable group such as a physiologically acceptable alcohol; and R 6 is a 1-6C alkyl, phenyl, etc.), or a physiologically acceptable salt thereof except when R 5 is other than H. n EXAMPLE: 4[(2-Butyl-1H-benzimidazol-1-yl)methyl]-N-phenylsufonylbenzamide. n USE: A remedy for hypertension, congestive heart failure, aldosteronism or other diseases or symptoms in which the renin-angiotensin-aldosterone system plays are remarkable causative role. n PREPARATION: Q of a compound of formula IV (wherein Q is protected COOH) is converted into COOH, and the resulting compound is optionally reacted with a compound of formula; NH 2 SO 2 R 6 or R 5 OH to obtain the compound of the formula I (wherein Z is formula II or III). n COPYRIGHT: (C)1991,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9204343-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008514704-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015518863-A
priorityDate 1989-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456357891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235190975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID919786

Total number of triples: 33.